Chloe Ramirez
Hepatitis A is a serious, highly contagious liver disease caused by the hepatitis A virus (HAV). It is spread through close contact with an infected person or by consuming food or water contaminated with the virus. While most people experience mild symptoms, hepatitis A can lead to severe complications and even death in rare cases. Fortunately, vaccines are available to prevent hepatitis A infection. The hepatitis A vaccine is safe and highly effective, offering long-term protection against the disease. It is recommended for children and adults, especially those at increased risk of infection, such as travellers to endemic areas. In addition to vaccination, practising good hygiene, including frequent handwashing, can help prevent the spread of hepatitis A. While there is no specific treatment for hepatitis A, supportive care, rest, and adequate nutrition and fluids are recommended to manage symptoms.
| Characteristics | Values |
|---|---|
| Prevention | Hepatitis A vaccine |
| Treatment | No specific treatment; doctors recommend rest, adequate nutrition and fluids to treat symptoms |
| Protection | Vaccination or immune globulin injection within two weeks of exposure |
| Risk factors | Chronic liver disease, HIV, drug use, homelessness, men who have sex with men, travel to countries with high rates of hepatitis A, close contact with infected persons or objects, food or drinks contaminated by feces of infected persons |
| Symptoms | Fever, nausea, abdominal pain, jaundice, liver failure, death |
| Vaccine side effects | Pain, redness, tenderness at injection site, headache, large hive-like swelling on face or body |
| Vaccine safety | Safe and highly effective, even for people with compromised immune systems; serious side effects very rare |
| Vaccine schedule | Two doses for children and adults, three doses for combination vaccine, administered over 6 months |
| Vaccine availability | Available at doctor's offices, pharmacies, and Local Health Units for children aged 18 and younger |
Explore related products
What You'll Learn
Hepatitis A vaccine is safe and effective
Hepatitis A is a serious liver disease that can cause death. It is caused by the hepatitis A virus (HAV) and is spread most often through infected food or water. The virus is primarily transmitted when an uninfected (and unvaccinated) individual consumes food or water that has been contaminated with the faeces of an infected person. The disease is closely associated with unsafe water or food, inadequate sanitation, poor personal hygiene, and oral-anal sex.
The hepatitis A vaccine is safe and effective. It is the best way to prevent infection and has been given to millions of people without causing any serious side effects. The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination for children aged 12-23 months and catch-up vaccination for children aged 2-18 years who have not previously received the vaccine. Vaccination is also recommended for unvaccinated adults who are at increased risk of infection or severe disease. Hepatitis A vaccines are highly effective in preventing HAV infection and have led to an 85% decrease in the number of hepatitis A cases in the United States.
There are two types of hepatitis A vaccines: single-antigen and combination. The single-antigen vaccine protects against hepatitis A, while the combination vaccine, Twinrix, protects against both hepatitis A and hepatitis B. The combination vaccine is only recommended for adults aged 18 and older. Both types of vaccines are safe and highly effective, even for people with compromised immune systems. The most common side effect is soreness, redness, and tenderness around the injection site. Other possible side effects include headaches and large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs. However, these side effects are usually mild and go away within a few days.
It is important to note that the hepatitis A vaccine should not be administered to individuals who have had a life-threatening allergic reaction to a previous dose or any of its ingredients. Before receiving the vaccine, individuals should inform their doctor if they have any severe allergies. Vaccination is recommended for individuals planning to travel to countries with moderate or high rates of hepatitis A. The CDC recommends getting vaccinated as early as possible, but even late vaccination can provide some protection. For full protection, two or three shots are required, depending on the type of vaccine.
Hep A Vaccine: Lifetime Protection or Booster Needed?
You may want to see also
Explore related products
Hepatitis A vaccine side effects
Vaccination is the best way to prevent hepatitis A infection. The hepatitis A vaccine is safe and highly effective, and millions of doses have been administered since it was first licensed in 1995. The vaccine is generally safe for people with compromised immune systems, and there are no known serious side effects.
However, as with any medicine, there is a small risk of a serious reaction. The most common side effects are usually mild and last 1-2 days. These may include soreness at or around the injection site, mild headache, loss of appetite (among children), and feeling tired.
In rare cases, more severe side effects may occur, such as an allergic reaction, which can be life-threatening. Individuals with a history of severe allergies or allergic reactions to the hepatitis A vaccine or its ingredients should not receive the vaccine.
It is important to weigh the risks and benefits of vaccination, and individuals should consult their healthcare provider to determine if the hepatitis A vaccine is right for them.
Protecting Yourself: TDAP Vaccine Frequency
You may want to see also
Explore related products
Who should get the hepatitis A vaccine?
Vaccination is the best way to prevent hepatitis A, a serious liver disease that can cause death. The hepatitis A vaccine is safe and highly effective, even for people with compromised immune systems. It can be administered to children concurrently with other vaccines, and it is recommended for all children between 12 months and 18 years of age living in the United States. Children need two doses of the vaccine, with the second dose administered at least six months after the first. Those up to 18 years old who have not been vaccinated against hepatitis A should also get the vaccine.
The Advisory Committee on Immunization Practices (ACIP) recommends hepatitis A vaccination for unvaccinated adults who are at increased risk of infection or severe disease from infection. Adults who are at risk for hepatitis A can get the vaccine in two doses, with the shots given 6 to 18 months apart. Adults who are at risk for both hepatitis A and hepatitis B may be able to get a combination vaccine that protects against both diseases.
The hepatitis A vaccine is also recommended for people who are considered to be at an increased risk of infection, including:
- Those travelling to countries with moderate or high rates of hepatitis A
- Those in close contact with a child adopted from a country with moderate or high rates of hepatitis A
- People who have been exposed to hepatitis A in the last two weeks (known as postexposure prophylaxis)
- People with chronic liver disease, including hepatitis B and hepatitis C
- People with human immunodeficiency virus (HIV)
- Pregnant women
- Military personnel
- People living in or moving to areas with a high rate of HAV infection and who are at high risk of HBV infection
- Males who have sex with males
- People who use illegal injection drugs
- People at risk through their work, such as laboratory workers who handle live hepatitis A and hepatitis B viruses, police, and those who give first aid or medical help, and workers who come into contact with stool or sewage
- People who work in child daycare centres and correctional facilities, residents of drug and alcohol treatment centres, and patients and staff in hemodialysis units
Understanding Viral Vector Vaccines: Host Synthesis of Antigens
You may want to see also
Explore related products
When to get the hepatitis A vaccine
The hepatitis A vaccine is the best way to prevent infection. Vaccination is recommended for all children and unvaccinated adults who are at an increased risk of infection or severe disease.
The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination for children aged 12-23 months and catch-up vaccination for children aged 2-18 years who have not previously received the vaccine. The hepatitis A vaccine is given in two doses, with children receiving their shots 6 months apart.
Unvaccinated adults who are at an increased risk of infection or severe disease from hepatitis A should also be vaccinated. This includes people with chronic liver disease, including hepatitis B and hepatitis C, people with HIV, pregnant women, and travellers to countries with high rates of hepatitis A.
The hepatitis A vaccine can be administered concurrently with other vaccines, and there is no evidence that this reduces the vaccine's response or effectiveness. The single-dose hepatitis A vaccine is typically administered as two shots over 6 months, while the combination vaccine is given as three shots over 6 months.
It is important to note that people with moderate or severe illnesses should wait until they recover before getting vaccinated. Additionally, anyone with a history of severe allergic reactions to any vaccine components should not receive the hepatitis A vaccine.
T Cells: Influenza Vaccine's Long-Lasting Legacy
You may want to see also
Explore related products
Hepatitis A treatment and management
Hepatitis A is a highly contagious liver disease caused by the hepatitis A virus (HAV). It is typically spread through close contact with an infected person or by consuming contaminated food or water. While most cases of hepatitis A are mild, the disease can cause severe illness and even lead to liver failure and death in rare cases.
Vaccination:
The best way to prevent hepatitis A infection is by getting vaccinated. The hepatitis A vaccine is safe and highly effective, offering long-term protection against the disease. It is recommended for children between 12 months and 18 years of age and adults who are at increased risk of infection. This includes individuals with certain risk factors such as travel to endemic areas, drug use, HIV, chronic liver disease, homelessness, and men who have sex with men. The vaccine is usually given in two doses, with the second dose administered at least six months after the first.
Post-exposure Prophylaxis:
For individuals who have been exposed to hepatitis A, post-exposure prophylaxis is crucial. Unvaccinated individuals exposed to the virus should receive the hepatitis A vaccine or an immune globulin injection within two weeks of exposure. Immune globulin provides short-term protection and can help reduce the severity of the illness if infection occurs.
Treatment and Management:
Currently, there are no specific treatments for hepatitis A once an individual is infected. Management of the disease focuses on supportive care, including rest, adequate nutrition, and fluid intake. In some cases, hospitalisation may be required for additional medical care. Symptoms typically last for a few weeks but can persist for several months. Most people recover from hepatitis A without significant interventions, but some may require more extensive healthcare to manage their illness.
Novavax: How Does It Differ From Other Vaccines?
You may want to see also
Frequently asked questions
There is no specific antiviral treatment for hepatitis A. Supportive care is recommended to relieve symptoms and ensure adequate hydration and nutrition. Hospitalization is not necessary unless there is severe disease or acute liver failure.
Yes, there are several safe and effective vaccines available to prevent hepatitis A. The hepatitis A vaccine is recommended for all children between 12 months and 18 years of age. It is also recommended for adults who are at increased risk of infection, such as those with chronic liver disease, HIV, or those who are pregnant.
The most common side effect is soreness, redness, and tenderness around the shot site. A headache has been reported in about 5 out of every 100 recipients. Serious side effects are very rare, and the potential risks of hepatitis A are much higher than any risks associated with the vaccine.
